1. Home
  2. MATW vs ALT Comparison

MATW vs ALT Comparison

Compare MATW & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Matthews International Corporation

MATW

Matthews International Corporation

HOLD

Current Price

$20.76

Market Cap

676.1M

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$3.26

Market Cap

573.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MATW
ALT
Founded
1850
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
676.1M
573.8M
IPO Year
1995
2005

Fundamental Metrics

Financial Performance
Metric
MATW
ALT
Price
$20.76
$3.26
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.67
AVG Volume (30 Days)
803.8K
4.2M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
3.67%
N/A
EPS Growth
59.07
25.37
EPS
N/A
N/A
Revenue
$1,795,737,000.00
$41,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
105.00
52 Week Low
$20.21
$2.56
52 Week High
$30.93
$6.44

Technical Indicators

Market Signals
Indicator
MATW
ALT
Relative Strength Index (RSI) 27.53 59.73
Support Level N/A $3.18
Resistance Level $27.54 $3.32
Average True Range (ATR) 0.70 0.14
MACD -0.05 0.01
Stochastic Oscillator 16.64 82.29

Price Performance

Historical Comparison
MATW
ALT

About MATW Matthews International Corporation

Matthews International Corp is a provider of memorialization products, industrial technologies and brand solutions. The company's segments are Memorialization, Industrial Technologies and Brand Solutions. The memorialization offerings include bronze and granite memorials, caskets, and cremation-related products and equipment for cemeteries and funeral homes. Its Industrial Technologies segment designs, manufactures, services, and sells custom energy storage systems and product identification and warehouse automation solutions. The Brand Solutions segment provides brand management, pre-media, printing plates and cylinders, imaging, digital asset management, merchandising displays, and marketing and design services. The majority of revenue is generated by Memorialization.

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: